SYDNEY, N.S. — The Canada-based Cornerstone Research Group has been acquired by Eversana, a provider of commercial services to the life science industry.
Cornerstone, which has its headquarters in Burlington, Ont. and an additional location in Cape Breton, provides health economics and outcomes research services in its work with pharmaceutical and medical device service companies, according to a press release to announce the acquisition.
“Pharmaceutical companies face strong pressures to quickly assess and quantify both the direct and indirect value of their in-market products and development pipeline,” Jim Lang, Eversana CEO, said in a press release.
“By adding a strong health economics and outcomes capability to our integrated commercial platform, we can now conceptualize, deliver and measure value at every stage of the product lifecycle from clinical trials to ongoing patient adherence.”
Cornerstone Research Group will transition to the Eversana brand in the coming quarter, and the company’s partners will assume leadership roles at Eversana.
